Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
Open accessThe DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is an endocrine-gynecology disorder affecting many women of childbearing age. Although a part of the involved mechanism in PCOS occurrence is discovered, the exact etiology and pathophysiology are not comprehensively understood yet. We searched PubMed for PCOS pathogenesis and management in this article and ClinicalTrials.gov for information on repurposed medications. All responsible factors behind PCOS were thoroughly evaluated. Furthermore, the complete information on PCOS commonly prescribed and repurposed medications is summarized through tables. Epigenetics, environmental toxicants, stress, diet as external factors, insulin resistance, hyperandrogenism, inflammation, oxidative stress, and obesity as internal factors were investigated. Lifestyle modifications and complementary and alternative medicines are preferred first-line therapy in many cases. Medications, including 3-hydroxy-3-methyl-3-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors, thiazolidinediones, sodium-glucose cotransporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors, glucose-like peptide-1 receptor agonists, mucolytic agents, and some supplements have supporting data for being repurposed in PCOS. Since there are few completed clinical trials with a low population and mostly without results on PCOS repurposed medications, it would be helpful to do further research and run well-designed clinical trials on this subject. Moreover, understanding more about PCOS would be beneficial to find new medications implying the effect via the novel discovered routes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hyperandrogenism, hyperinsulinism and insulin resistance (IR) are the main drivers of clinical, metabolic and reproductive phenotypes of PCOS.”
From Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents (2023) · cites this paper as [3]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Similarly, the DAI has been developed as a more specific measure of adipose tissue dysfunction by combining WC, BMI, TG levels, and HDL-C [9,10,11].”
From Visceral and Dysfunctional Adiposity Indices as Predictors of Insulin Resistance and Metabolic Syndrome in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The VAI is an established marker of abdominal obesity and IR, integrating WC, triglyceride (TG) levels, and high-density lipoprotein cholesterol (HDL-C) to predict metabolic risk.”
From Visceral and Dysfunctional Adiposity Indices as Predictors of Insulin Resistance and Metabolic Syndrome in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study (2025) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083 · cited 3×
“In addition, it should be mentioned that studies on PCOS women approved the resemblance of their fatty tissue to men, and hence the effect of HA on adipose tissue dysfunction [8].”
BackgroundInfluentialRosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603 · cited 9×
“Hyperinsulinemia increases LH-binding sites and androgen-producing response to LH [44].”
BackgroundInfluentialChronic Low Grade Inflammation in Pathogenesis of PCOS
Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., Smolarczyk, R., & Meczekalski, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073789 · Cited by 680
Witchel, S. F., Oberfield, S. E., & Peña, A. S. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00078 · Cited by 653
Sanchez-Garrido, M. A., & Tena-Sempere, M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.001 · Cited by 557 · cited 1×
“One way androgen results in oxidative stress is by increasing MNC sensitivity to glucose and aggravating glucosestimulated oxidative stress [65].”
BackgroundPolycystic Ovarian Syndrome: Correlation Between Hyperandrogenism, Insulin Resistance and Obesity.
Zeng, X., Xie, Y.-J., Liu, Y.-T., Long, S.-L., & Mo, Z.-C. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.11.003 · Cited by 525 · cited 9×
“It also plays a role in progesterone and estrogen production, ovulation, and decreased GnRH secretion [52].”
BackgroundInfluentialA novel and compact review on the role of oxidative stress in female reproduction
Lu, J., Wang, Z., Cao, J., Chen, Y., & Dong, Y. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0391-5 · Cited by 481 · cited 11×
“Taking SFAs induces inflammation by triggering an increase in TNF-α level in circulation and expressing a specific cytokine suppressor [36].”
BackgroundInfluentialIbáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., Dabadghao, P., Darendeliler, F., Elbarbary, N. S., Gambineri, A., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479371 · Cited by 463 · cited 7×
“This receptor hypomethylation leads to higher gene expression and sensitivity to LH [18,20].”
BackgroundInfluentialCharacteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics
Glueck, C. J., & Goldenberg, N. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.002 · Cited by 442 · cited 3×
“Excess abdominal fat is also responsible for the inflammatory condition [6,44,81].”
BackgroundCassar, S., Misso, M. L., Hopkins, W. G., Shaw, C. S., Teede, H. J., & Stepto, N. K. (2016) · Human Reproduction · doi:10.1093/humrep/dew243 · Cited by 415 · cited 1×
“On the other hand, hyperinsulinemia reduces hepatic SHBG [18,32,40,49,52,54–56], increasing free testosterone levels in blood [18,32,52,54,56].”
Background
Research works printed but not linked: 4
- Maloy, S., and Hughes, K. (2013). Epigenetics. Brenner’s Encyclopedia of Genetics, Academic Press. [2nd ed.].
- Worsfold, P., Poole, C., Townshend, A., and Miró, M. (2019). Endocrine Disrupting Chemicals. Encyclopedia of Analytical Science, Academic Press. [3rd ed.].
- Zeind, C.S., and Carvalho, M.G. (2017). Applied Therapeutics: The Clinical Use of Drugs, Wolters Kluwer Health.
- Mohseni, 2021, Yoga Effects on Anthropometric Indices and Polycystic Ovary Syndrome Symptoms in Women Undergoing Infertility Treatment: A Randomized Controlled Clinical Trial, Evid.-Based Complement. Altern. Med., 2021, 1, 10.1155/2021/5564824 · DOI
Cited by
Items 201–300 of 497
Kriplani, A., Tank, P. D., Singh, P., Maini, N., Kaitala, S., Lakshmi Kantha, G., Paul, J., Shah, S., Bhatara, U., Sinha, A., et al. (2024) · Cureus · doi:10.7759/cureus.75616 · Cited by 7
Khademi, Z., Pourreza, S., Shahraki, S. H., & Amirkhizi, F. (2023) · Biological Trace Element Research · doi:10.1007/s12011-023-03935-2 · Cited by 5
“Adiponectin is an anti-inflammatory adipokine with insulin-sensitizing properties that plays a key role in promoting ovulation and the production of estrogen and progesterone [11, 12].”
Oxidative stress modulates endocrine profiling in polycystic ovarian syndrome patients
Mughal, I. A., Hussain, G., Mukhtar, I., Irfan, S., & Anwar, H. (2023) · Asian Journal of Agriculture and Biology · doi:10.35495/ajab.2023.212 · Cited by 4
Women’s Healthcare: Call for Action
Young, W. B. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01135 · Cited by 6
Jiang, L., Chen, Y., & Huang, M. (2024) · Technology and Health Care · doi:10.1177/09287329241296228 · Cited by 5
Chemically-induced histopathological progression in the polycystic ovary syndrome (PCOS)- A review
Javed, M., Suramya, S., Ahmad, S., & Raisuddin, S. (2025) · Toxicological Research · doi:10.1007/s43188-025-00296-x · Cited by 4
“Among them, EDCs are major drivers involved in the excess production of androgens and the imbalance of hormones, consequently leading to anovulation, infertility, disruptive ovarian functions, polycystic ovaries, and other histopathological alterations [3, 12, 13].”
Li, X., & Peng, X. (2025) · Gynecological Endocrinology · doi:10.1080/09513590.2025.2504980 · Cited by 4
Liang, Y., Zhang, Q., & Lou, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1545508 · Cited by 4
Abd, A. N., Abu-Raghif, A. R., Al‐Anbari, L. A., & Ridha‐Salman, H. (2025) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.15.3.3 · Cited by 4
Wang, Y., Shen, D., Zhu, C., Sun, W., Qian, Y., & Yang, H. (2025) · Women s Health Reports · doi:10.1177/26884844251395123 · Cited by 4
“39 The health inequality metrics align with the observed patterns.”
InfluentialChoi, L. Y., Kwon, S., So, S., Jeon, Y., Kim, D. Y., & Kim, M. H. (2025) · Reproductive Sciences · doi:10.1007/s43032-025-02027-x · Cited by 3
“Standard pharma - cological interventions for PCOS typically include ovulation inducers (e.g., clomiphene citrate, letrozole), insulin sensitizers (e.g., metformin), and combined oral contraceptives [10, 11].”
Sun, N., Sun, P., Sun, L., Sun, P., Qi, D., & Ma, H.-G. (2026) · PLoS ONE · doi:10.1371/journal.pone.0342158 · Cited by 3
“Reports indicated that the prevalence rates of insulin resistance in PCOS patients range from 44% to 70% [2].”
Pinton, P. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1787902 · Cited by 3
Yang, H., Zhao, S., Yang, L., Quan, X., Xue, X., Liu, Y., Yao, K., Wang, R., Liu, Q., Zou, K., et al. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124392 · Cited by 4
Onaolapo, O. J., Aworinde, O., Olufemi-Aworinde, K. J., & Onaolapo, O. J. (2026) · Acta Bioscientia Journal of Biomedical and Biological Science Research · doi:10.71181/actabioscientia12550 · Cited by 3
Popa, E., Chiş-Şerban, A.-A., & Coman, A. E. (2023) · Medic ro · doi:10.26416/med.151.1.2023.7837 · Cited by 3
Yamarthi, P., Kotipalli, R., Patnaik, S. S., Veena, K. V., Kathirvel, M., Vutukuri, R., & Bhanoori, M. (2024) · Pathophysiology · doi:10.3390/pathophysiology31030031 · Cited by 3
“This triggers the ovarian cells to produce more androgens [29].”
BackgroundAlshiekh, A., Hadakie, R., Kurdi, M. F. A., sukkar, L., Alhalabi, M., & Hamed, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-85544-8 · Cited by 5
Mishra, S., & Mittal, P. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100741 · Cited by 3
Begum, I. A., Hosen, A. S. M. S., Ghimire, D., & Park, M. J. (2025) · Diagnostics · doi:10.3390/diagnostics15060711 · Cited by 5
Therapeutic Potential of GeGen Decoction for the Treatment of Polycystic Ovary Syndrome
Qian, Y., Bayoude, A., Zhou, H., Shen, Y., & Chai, C. (2025) · The FASEB Journal · doi:10.1096/fj.202500192rr · Cited by 3
Low serum hepcidin levels in women with polycystic ovary syndrome: evidence from meta-analysis
Nong, J., Li, H., Yang, Y., Qing-hong, L., Sun, Y., Yin, Q., & Hongying, H. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2024.2375568 · Cited by 6
Olavarría-Guadarrama, M., Aguayo-González, P., Reséndiz, V. A. B., Castro-López, J. L., Pérez, L. O. D. L. O., Elizarrarás-Cendejas, J. L., Flores-Robles, C. M., Hernández-Marín, I., Lanuza-López, M. C., Luna-Rojas, M. R., et al. (2024) · Perinatología y Reproducción Humana · doi:10.24875/per.24000019 · Cited by 7
Evaluation of serum calprotectin levels in patients with polycystic ovary syndrome
Şener, R., Alataş, E., & Güler, T. (2025) · Scientific Reports · doi:10.1038/s41598-025-99445-3 · Cited by 3
Yao, Y., Liu, Y., Li, Y., Xiao, N., Luo, H., & Wang, S. (2026) · Environmental Chemistry and Ecotoxicology · doi:10.1016/j.enceco.2026.01.017 · Cited by 3
Prediction a woman having Polycystic Ovary Syndrome (PCOS) those having Insulin Resistance (IR)
Talib, I., Khadija, S., Khan, A. M., Akram, S., Akhtar, M. K., Willayat, F., & Iftikhar, A. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs221626 · Cited by 3
Costa, J. R. P., Simões, M. E. C., Silva, M. L. P. E., Sasso, V. P. D., Rocha, I. R., Figueiredo, R. A. H., Silva, I. F., Ribeiro, L. P., Gonçalves, T. C. D., & Aquino, I. P. D. (2023) · Brazilian Journal of Development · doi:10.34117/bjdv9n3-223 · Cited by 7
Pouraghajan, K., & Mohamadpour, M. (2023) · Research Square · doi:10.21203/rs.3.rs-3402313/v1 · Cited by 3
Xia, D., Xu, L., Cheng, X., Li, C., Chen, S., & Zhang, Y. (2024) · African Journal of Reproductive Health · doi:10.29063/ajrh2024/v28i12.14 · Cited by 2
Evaluation of Retinal Changes in Women with Different Phenotypes of Polycystic Ovary Syndrome
Sümer, F., Gürlek, B., Yıldız, E., Uzun, F., Çolak, S., & Ayazoğlu, İ. M. (2025) · Diagnostics · doi:10.3390/diagnostics15020227 · Cited by 2
Bhatia, D. S., Sharma, D., Shah, K., Alam, P., & Dewangan, H. K. (2025) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2025.104532 · Cited by 2
NAT10 mediated polycystic ovary syndrome through the ac4C modification of CXCL14
Wang, D., Li, H., Wang, Q., & Liu, Y. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106767 · Cited by 2
Cao, Q., Liu, D., Zhu, H., Wang, Q., Tan, J., Huang, X., Li, Y., Wang, R., Zhou, R., & Huang, W. (2025) · Gynecological Endocrinology · doi:10.1080/09513590.2025.2530566 · Cited by 3
“The vicious cycle of interacting endocrine-metabolic disorders underlies PCOS pathogenesis [9–13].”
Lyu, Y., Cai, L., & Li, M. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1609131 · Cited by 2
Cîrstoiu, S.-E., & Mehedințu, C. (2023) · Romanian Journal of Preventive Medicine · doi:10.3390/rjpm2030037 · Cited by 2
“In some cases, it is recommended to consider using complementary and alternative medicine strategies (2).”
Zahra, M., Shah, M., Iqbal, F., Zubair, T., Habib, R., & Zulfiqar, F. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04626-6 · Cited by 2
“Since elevated LH in PCOS reflects abnormal GnRH pulse frequency and contributes to hyperandrogenism and anovulation (Sadeghi et al. 2022), this greater decline may indicate a stronger central reproductive axis modulation in the nutraceutical arm, potentially mediated by L-carnitine’s effects on…”
Crespo, P., Herranz, N., Estella, V., Morencos, E., Herranz, M., & Rodas, G. (2025) · Frontiers in Sports and Active Living · doi:10.3389/fspor.2025.1642415 · Cited by 2
Bakar, S., Arpa, M., Kuruca, N., & Şentürk, Ş. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70725 · Cited by 2
“2,3 Given the multifactorial nature of PCOS, attention has increasingly turned to intra-ovarian signaling pathways that might integrate reproductive and metabolic disturbances.”
Pulluparambil, S. J., & Bhat, S. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106933 · Cited by 2
Peng, C., Wang, C., Chen, J., & Chen, H. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02049-2 · Cited by 3
“HSP90 inhibitors (e.g., 17-AAG) partially reverse these phenotypes [38].”
Unraveling the mechanisms of PCOS: the interplay between gut microbiota and the immune system
Liu, J., Wang, L., Jiang, M., Yan, H., Zhang, G., Li, N., Zhao, Y., Du, X., Zeng, Q., Xiong, D., et al. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02047-4 · Cited by 4
Abomughaid, M. M. (2026) · Chemistry & Biodiversity · doi:10.1002/cbdv.202502535 · Cited by 2
Aziz, M. (2023) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.473 · Cited by 6
Multiomics in polycystic ovarian syndrome
Jabeen, F., Ahmad, R., Rasool, S., Ali, A., & Ganie, S. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23971-7.00010-9 · Cited by 4
Association between polycystic ovary syndrome in adolescent girls and vitamin D levels
Sorokman, Т. V., Комшук, Т. С., Sokolnyk, I. S., & Moldovan, P. M. (2024) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.20.3.2024.1388 · Cited by 2
Liu, H., Liu, Y., Wei, C., Zhang, S., & Xu, Y. (2024) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-024-03760-z · Cited by 2
Shukla, R., Chadha, M., Adya, A., Yadav, A., Singh, N., Chauhan, R. S., Ahmad, A., & Tiwari, R. K. (2024) · Reviews on Recent Clinical Trials · doi:10.2174/0115748871325070241008101355 · Cited by 5
Effect of nanocurcumin on fertility in murine model of polycystic ovary syndrome.
Aaly-Gharibeh, Z., Hosseinchi, M., & Jalali, A. S. (2024) · PubMed Central · doi:10.30466/vrf.2023.2006604.3935 · Cited by 8
Jamwal, S., & Soni, A. (2024) · Journal of Applied Pharmaceutical Research · doi:10.18231/j.joapr.2024.12.2.1.15 · Cited by 3
Barman, I., Sharma, T., & Talukdar, N. (2024) · Journal of Young Pharmacists · doi:10.5530/jyp.2024.16.25 · Cited by 2
“11 Additionally, PCOS-related genes shown to be involved in ovarian and hormonal control may potentially affect thyroid and hormone production.”
Rockenbach, M. K., Fraga, L. R., Kowalski, T. W., & Sanseverino, M. T. V. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1125097 · Cited by 2
“PCOS is a multifactorial disorder, influenced by intrinsic and extrinsic factors, such as insulin resistance, hyperandrogenism, environmental factors, genetics, and epigenetics (Sadeghi et al., 2022).”
BackgroundNarani, M. S., Vatannejad, A., Kheirollahi, A., Teimouri, M., Bayat, S., & Jadidzadeh, F. (2023) · Acta Biochimica Iranica · doi:10.18502/abi.v1i3.14547 · Cited by 2
Comparative Management Methods for Adolescents With Polycystic Ovarian Syndrome: A Systemic Review
Vadan, R. L., Varela, N., Zhuravko, N., Ogidan, N. O., Adedara, V. O., & Keku, E. O. (2024) · Cureus · doi:10.7759/cureus.55876 · Cited by 3
“(2022) [6] The pathogenesis of PCOS relies on the increased levels of androgens.”
BackgroundZhang, C., Yan, D., Wang, X., & Cheng, D. (2023) · Medicine · doi:10.1097/md.0000000000032312 · Cited by 3
Uncovering the Cellular and Molecular Landscape of Gynecological Disorders
Yang, Q. (2025) · Cells · doi:10.3390/cells14171399 · Cited by 3
Diagnostic value of anti-Mullerian hormone in adolescent girls with polycystic ovary syndrome
Sorokman, Т. V., Makarova, O. V., & Ostapchuk, V. G. (2022) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.18.3.2022.1164 · Cited by 2
Pilehvari, S., Radnia, N., Ahmadiani, S., Ghane, E. T., Alimohammadi, N., & Tokaldani, Z. M. (2023) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v21i11.14655 · Cited by 1
Tunçcan, E., Mohri, P., Dikeç, M., Karaawi, F., Kazaz, E., Kocatepe, C., Dokuzlu, G., Tıraş, B., Çakıroğlu, Y., & Korun, Z. E. U. (2024) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.16092 · Cited by 2
Fatima, S., Mohapatra, L., Mishra, D., Tripathi, A. S., & Khan, A. A. (2025) · Reproductive Sciences · doi:10.1007/s43032-024-01771-w · Cited by 1
Permadi, I. G. N. W., & Prasetyaji, I. W. (2025) · Majalah Obstetri & Ginekologi · doi:10.20473/mog.v33i12025.44-52 · Cited by 2
Zhang, S., Zhu, M., & Chen, S. (2025) · Biochemical Genetics · doi:10.1007/s10528-025-11104-4 · Cited by 1
Zhu, Z., Nazar, R. B. M., Zuo, X., Yang, K., Wu, T., Zhang, Y., He, C., Xu, K., He, Y., & Li, C. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01697-0 · Cited by 1
“It is often associated with menstrual irregularities, hyperandrogenism, enlarged dysfunctional ovaries, insulin resistance, obesity, and reproductive challenges [3].”
Yan, S., Zeng, X., & Lü, X. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02648-8 · Cited by 1
Huang, P., Jiang, S., Zheng, B., Fu, Y., You, W., & Li, H. (2025) · American Journal of Translational Research · doi:10.62347/zuhl5679 · Cited by 1
Terzian, N., Nordlund, S., & Bassilious, E. (2025) · Therapeutic Advances in Reproductive Health · doi:10.1177/26334941251368257 · Cited by 1
Exploring critical hub genes and potential drug candidates for PCOS: A systems biology approach
Firouzjaei, A. A., Mahmoudi, A. A., Elizova, N. V., Kesharwani, P., & Sahebkar, A. (2025) · Reproductive Biology · doi:10.1016/j.repbio.2025.101078 · Cited by 2
Bezdoode, M. F., Kalhori, Z., Razlansari, R., & Jamshidi, A. (2025) · Cell and Tissue Biology · doi:10.1134/s1990519x25600619 · Cited by 2
Alhebshi, Z. A., Alqarni, D. H., Najjar, A. A., Alshalahi, S. S., Alhatlani, R. A., Jamal, A., Wasaya, H. I., Almehmadi, M., Alrafi, M. A., & AlHabardi, N. (2025) · Reproductive Sciences · doi:10.1007/s43032-025-01979-4 · Cited by 1
“Letrozole and clomiphene citrate (CC) are the most widely used medications for this purpose [ 3 ].”
Lee, B., Lee, G., Choi, L. Y., Kwon, S., Jeon, Y., Kim, M. H., & Kim, S. H. (2025) · Food Science and Biotechnology · doi:10.1007/s10068-025-02019-2 · Cited by 1
“Metformin commonly induces gastrointestinal symptoms such as nausea and vomiting during the initial phase of treatment (Sadeghi et al., 2022).”
王, 书. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15113126 · Cited by 1
Fu, M., Deng, F., Chen, J., Wen, M., Zhu, X., Fu, L., Guan, J., Qiu, J., Gao, Q., & Ding, H. (2025) · BMC Women s Health · doi:10.1186/s12905-025-04237-6 · Cited by 1
“Polycystic ovary syndrome, a multifaceted hormonal disorder prevalent in women of reproductive age, has been associated with obesity, insulin resistance, and hyper-androgenemia, and extrinsic factors such as stress and diet have also been implicated [54].”
Li, Z., Peng, Q., Lin, Y., Li, Z., Li, X., Zhao, J., & Zhu, C. (2026) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-25-0176 · Cited by 1
A network meta-analysis of interventions for anxiety and depression in PCOS
Tan, Z., Li, Y., Liu, J., Hu, X. M., Su, X., & Huang, Y. (2026) · PeerJ · doi:10.7717/peerj.20744 · Cited by 2
“Pharmacological treatments, including oral contraceptives, insulin sensitizers, and anti-androgen medications are widely used to regulate menstrual cycles, improve metabolic parameters, and reduce androgen levels ( Sadeghi et al., 2022 ).”
Zhu, X., Xu, W., & Lu, A.-F. (2026) · Reproductive Toxicology · doi:10.1016/j.reprotox.2026.109233 · Cited by 1
Liu, Y., 吴若妍, Li, H., Pu, D., Wang, X., Chen, S., Jiang, C., Hu, W., Wang, L., Ye, X., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158243 · Cited by 2
Phung, T. M., Nguyen, H. C., Ho, D. N., Thach, T. M. H., Nguyen, T. P., Nguyen, V. N. T., Lâm, Đ. T., & Nguyen, T. H. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-026-00340-2 · Cited by 1
Sequeira, A. W., Sutar, K. P., Biradar, P. R., Naik, S., Dsouza, K. X., Jadhav, A., & Sammasagi, S. S. (2026) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2026.2675474 · Cited by 1
刘滨松, Rashid, M. H., Bai, X., An, R., Feng, Y., & Cui, C. (2026) · Tropical Medicine and Health · doi:10.1186/s41182-026-01005-6 · Cited by 2
“Common clinical features include irregular menstruation, hir-sutism, acne, and obesity [14].”
Komre, P., Gupta, A., Shah, K., Verma, N., Chauhan, N. S., Sahu, S., Tiwle, R., & Gupta, S. (2026) · Pharmacological Research - Reports · doi:10.1016/j.prerep.2026.100101 · Cited by 1
Suhendi, J. R. (2023) · Prosiding Workshop dan Seminar Nasional Farmasi · doi:10.24843/wsnf.2022.v02.p02 · Cited by 2
“Diketahui bahwa penyebab dasar dari PCOS adalah tingginya rasio luteinizing hormon (LH) terhadap hormon perangsang folikel (FSH) serta peningkatan frekuensi gonadotropin hormone-releasing hormone (GnRH) [2].”
BackgroundOvarios poliquísticos como factor de riesgo cardiometabólico para hipertensión arterial
Moreno-Ruíz, L. A., Madrid-Miller, A., Necoechea-Osuna, Y., & Vega-Gutiérrez, J. J. (2024) · Cardiovascular and Metabolic Science · doi:10.35366/115056 · Cited by 1
Estimation the level of Neudesin in Polycystic ovarian syndrome patients
Salih, S. I., & Al-Dujaili, A. N. (2024) · BIO Web of Conferences · doi:10.1051/bioconf/202410804012 · Cited by 1
Use of GLP-1 Receptor Agonists in the Treatment of Obesity in Women with PCOS
Jaroń, A., Wiklińska, A., Jastrzębska, K., Witkowska, M., Skotnicka, J., Błaszczak, K., Turek, M., Wojciechowska, K., Borkowski, A., & Sawicki, M. (2024) · Quality in Sport · doi:10.12775/qs.2024.20.53831 · Cited by 2
PCOS – The Importance of Diet, Physical Activity, and Other Non-Pharmacological Methods in Treatment
Turek, M., Wojciechowska, K., Jaroń, A., Jastrzębska, K., Wiklińska, A., Witkowska, M., Skotnicka, J., Błaszczak, K., Borkowski, A., & Sawicki, M. (2024) · Quality in Sport · doi:10.12775/qs.2024.19.53833 · Cited by 1
Ling, S., Huang, L.-Y., Lia, T., Xie, D., Xiao, Q., Tian, C., & Li, Q. (2024) · Medicine · doi:10.1097/md.0000000000040162 · Cited by 2
“Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age [1,2] ; it is a lifelong reproductive, metabolic, and psychological disorder that affects 5% to 18% of women.”
BackgroundFeng, W., Xie, X., Su, Y. A., Jin, R., & Shi, W. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2024.2439886 · Cited by 2
Prevalence of Urinary Tract Infections in Polycystic Ovarian Syndrome at Al-Muthanna Province, Iraq
Kadhim, T. A., Jabbar, S. M., Ghazi, M. H., Sadiq, S. S., & Al-Hilli, N. M. (2025) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_637_24 · Cited by 1
Exploring the overlooked risk: Ocular health and alterations in women with polycystic ovary syndrome
Pandey, H., Sharma, N., Kritika, K., & Alam, A. (2025) · European Journal of Ophthalmology · doi:10.1177/11206721251337584 · Cited by 1
Li, D., Lei, L., Liu, L., Wang, Y., Yang, C., Wang, W., & Luo, B. (2025) · Medicine · doi:10.1097/md.0000000000043207 · Cited by 1
Huang, X., & Yu, F. (2025) · Gynecological Endocrinology · doi:10.1080/09513590.2025.2536579 · Cited by 1
“Currently known causative factors include epigenetic factors, environmental triggers, and internal factors such as insulin resistance, hyperandrogenism, inflammation, oxidative stress, and obesity [2].”
Aolymat, I., Abumweis, S., Al-Momani, H., Abu-Hassan, D. W., AlBarakat, M. M., Alzoubi, A., saleh, M. A., Oleimat, A. K., Amin, S. N., Gazzar, W. B. E., et al. (2025) · Metabolites · doi:10.3390/metabo15100654 · Cited by 3
Ha, L., Wang, J., Yuan, Y.-Y., Liu, H., & Yang, J. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s543184 · Cited by 1
Zhang, H., Di, M., Wang, Y., Ma, Y., Gou, Y., & Zhou, Z. L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1671511 · Cited by 1
“The exact pathogenesis of PCOS is not yet fully understood, but it is widely believed that genetic, environmental, and lifestyle factors play a major role in its development (7).”
Huang, X., Zhang, S., Liang, D., Qiu, L., Wu, R., Wei, R., Chen, X., & Huang, S. (2026) · European journal of medical research · doi:10.1186/s40001-025-03734-6 · Cited by 1
“PCOS is often associated with obesity and insulin resistance, which increase the risk of type 2 diabetes, cardiovascular disease, and endometrial cancer [2].”
Wei, S., Qin, T. G., Li, Y., Zhang, D., Liu, L. A., Wei, L., & Zhao, R. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04970-7 · Cited by 1
Hemalatha, M., Subashini, S. P., & Sharma, P. (2026) · Indian Journal of Obstetrics and Gynecology Research · doi:10.18231/j.ijogr.8970.1762169082 · Cited by 2
Yin, M. X. C., Huang, M.-Y., Zhao, Y.-F., & Chen, X.-Y. (2026) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2026.102719 · Cited by 1
Abduljabbar, H., Jamal, M., & Esmat, A. (2026) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010433981251031050335 · Cited by 1
Association between the diabetes risk reduction diet and polycystic ovary syndrome
Jamalvandi, M., Fateh, H. L., Ahmadi, T., Moludi, J., Samadi, M., & Moradinazar, M. (2026) · BMC Nutrition · doi:10.1186/s40795-026-01281-9 · Cited by 1
“The pathophysiology of PCOS is complex and multifactorial, involving genetic predisposition, hormonal imbalances, and environmental factors [3], among which diet plays a pivotal role [7].”
Pourkhani, Z., Moini, A., Sadatmahalleh, S. J., Arabipoor, A., & Ahmadi, F. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-025-00271-4 · Cited by 2
Metadata
- Authors
- Sadeghi, H. M., Adeli, I., Calina, D., Docea, A. O., Mousavi, T., Daniali, M., Nikfar, S., Tsatsakis, A., & Abdollahi, M.
- Affiliations
- Pharmaceutical Sciences Research Center (IR)
- Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
- University of Medicine and Pharmacy of Craiova (RO)
- Personalized Medicine Research Center (IR)
- University of Crete (GR)
- Corresponding author
- Abdollahi, Mohammad
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-01-06
- Volume
- 23
- Issue
- 2
- Pages
- 583
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8775814
- OpenAlex
- W4205636865
- Cited by
- 445
- References
- 106
- Citations by year
- 2026: 68 · 2025: 136 · 2024: 133 · 2023: 90 · 2022: 18
- FWCI
- 15.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- polycystic ovary syndrome, PCOS pathogenesis, drug repurposing, insulin resistance, hyperandrogenism, oxidative stress, inflammation, obesity, epigenetics, environmental toxins, stress, diet, statins, thiazolidinediones, SGLT2 inhibitors, DPP-4 inhibitors, GLP-1 receptor agonists, mucolytic agents, lifestyle modification, complementary and alternative medicine
- MeSH terms
- Female, Humans, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Disease Management, Drug Repositioning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.